LLY - What's Going On With Eli Lilly Shares Monday? | Benzinga
Eli Lilly and Co (NYSE:LLY) shares are moving higher Monday following the release of positive Phase 3 trial results for its weight loss drug, tirzepatide, marketed as Zepbound.
What Happened: The trials, known as SURMOUNT-OSA, demonstrated significant improvements in moderate-to-severe obstructive sleep apnea (OSA) patients with obesity, Eli Lilly said late Friday.
Tirzepatide achieved a mean reduction of up to 62.8% on the apnea-hypopnea index (AHI) and showed disease resolution in over 40% of participants, defined ...